Invopressin presents a cyclic-like peptide framework that promotes defined molecular geometry in binding investigations. Distinct residues contribute to stability, polarity variation, and receptor-interaction modeling. The compound's behavior in solution assists studies of folding and intermolecular association. Research domains include signal-modulating peptides, sequence refinement, and structural mimicry.
CAT No: R2616
CAS No:1488411-60-4
Synonyms/Alias:Invopressin;1488411-60-4;OCE-205;Invopressina;Invopressine;invopressin [INN];GT7UX45K55;CHEMBL5314925;SCHEMBL17722524;HY-P5535;DA-64466;CS-0886345;[Phe^2,Ile^3,Dab(PhAc-D-Tyr(Me)-Phe-Gln-Asn-Ala-Pro-Arg-iGln-Lys(Ac)-Epsilon-Lys)^8]vasopressin;Glycinamide, L-cysteinyl-L-phenylalanyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-(2S)-4-[[N6-(N6-acetyl-L-lysyl)-L-lysyl]amino]-2-aminobutanoyl-, cyclic (1-->6)-disulfide, (8'''-->1'')-amide with O-methyl-N-(2-phenylacetyl)-D-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-alanyl-L-prolyl-L-arginyl-L-alpha-glutamine;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More